| Value | ₹0.27 Cr |
|---|
BSE filing, NSE: KJMCCORP. Summary written from the filing by ALFA Finder's alert engine.
KJMC Corporate Advisors (India) Ltd: key numbers
- Share price
- ₹55.00
- Market cap
- ₹21.60 Cr
- Revenue (annual)
- ₹12.32 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 10.7×Sector 20.8×
- Promoter holding
- 70.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KJMC Corporate Advisors (India) Ltd
All →KJMC Corporate Advisors (India) Board Meeting Date
KJMC Corporate Advisors will consider unaudited standalone and consolidated half-year results at a board meeting on 13 November 2026. Trading window stays closed until 17 November 2026.
KJMC Corporate Advisors (India) Other Announcement
The company filed the quarterly RTA certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.
KJMC Corporate Advisors (India) Annual General Meeting
KJMC Corporate Advisors held its 28th Annual General Meeting on September 29, 2026. Members considered agenda items, including financial statements, dividend declaration, and proposed fund-raising resolutions.
KJMC Corporate Advisors (India) Management Change
KJMC Corporate Advisors (India) Ltd announced the retirement of Independent Director Mr. Anil Sampat, effective September 21, 2026, upon the completion of his second term.
KJMC Corporate Advisors (India) Other Announcement
The company informed the exchange that it has dispatched letters to shareholders with unregistered email addresses, providing the weblink to access the Annual Report 2025-26.
KJMC Corporate Advisors (India) Dividend
KJMC Corporate Advisors (India) Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to the dividend for the financial year 2026.
Other financial results announcements
All →Caplin Point Laboratories Q2 FY27 Results: Net Profit ₹182.3 Cr, Up 13.8% YoY
Caplin Point Laboratories Ltd reported revenue from operations of ₹629.8 Cr (+17.9% YoY) and net profit of ₹182.3 Cr (+13.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹182.3 Cr · +13.8% YoY
Albert David Q2 FY27 Results: Turns Profitable, Net Profit ₹2.9 Cr
Albert David Ltd approved unaudited results for Q1 and H1 FY2027, with H1 profit before tax at Rs 4,088 Lakhs. The Board also placed the Statutory Auditor's review report before shareholders.
- Key figure
- Net profit ₹2.9 Cr
Dhunseri Investments Q2 FY27 Results: Turns Profitable, Net Profit ₹100.7 Cr
Dhunseri Investments Ltd reported revenue from operations of ₹203.2 Cr (+118.7% YoY) and net profit of ₹100.7 Cr for Q2 FY27.
- Key figure
- Net profit ₹100.7 Cr
Kwality Pharmaceuticals Q2 FY27 Results: Net Profit ₹29 Cr, Up 105.7% YoY
Kwality Pharmaceuticals Ltd reported revenue from operations of ₹181.2 Cr (+63.1% YoY) and net profit of ₹29 Cr (+105.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹29 Cr · +105.7% YoY
Taj GVK Hotels & Resorts Q2 FY27 Results: Net Profit ₹26.6 Cr, Down 3.6% YoY
Taj GVK Hotels & Resorts Ltd reported revenue from operations of ₹166.8 Cr (+55.6% YoY) and net profit of ₹26.6 Cr (-3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · -3.6% YoY
Cura Technologies Q2 FY27 Results: Net Loss of ₹0.2 Cr
Cura Technologies Ltd reported a net loss of ₹0.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.2 Cr